Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2Phase 1 1

Status

Recruiting 5Not yet recruiting 3Completed 1Active not recruiting 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 5

Conditions

Breast Neoplasms 3HR+/HER2- Early Breast Cancer 1HR+/HER2+ Early Breast Cancer 1

Interventions

Specimen Handling 302Magnetic Resonance Spectroscopy 261pembrolizumab 249Carboplatin 184Cyclophosphamide 175Biopsy 167Cisplatin 157Gemcitabine 134Paclitaxel 130Bevacizumab 123fludarabine 115Nivolumab 108Radiotherapy 107Oxaliplatin 88Docetaxel 87Fluorouracil 85Capecitabine 83venetoclax 78Dexamethasone 76Pemetrexed 72Rituximab 69Leucovorin 69Drug Therapy 69atezolizumab 67durvalumab 66Radiosurgery 65Blood Specimen Collection 64Doxorubicin 63Standard of Care 62Radiation 61

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Recruiting × Aromatase Inhibitors × 90 days × Clear all
NCT05879926 2026-06-03

OFSET

NRG Oncology

Phase 3 Recruiting
3,960 enrolled
Breast

Breast Neoplasms

NCT07222267 2026-06-03

An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors

BeOne Medicines

Phase 1 Recruiting
86 enrolled
Breast

Breast Neoplasms

NCT07616427 2026-06-01

TAYLOR-003

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 2 Recruiting
100 enrolled
Breast

HR+/HER2+ Early Breast Cancer

NCT07616453 2026-06-01

TAYLOR-002

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 2 Recruiting
45 enrolled
Breast

HR+/HER2- Early Breast Cancer

NCT07400523 2026-04-28

Ribociclib in Hormone Receptor-positive, HER2-negative Early Breast Cancer With Residual Disease After Neoadjuvant Chemotherapy

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 3 Recruiting
446 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡